175 related articles for article (PubMed ID: 24706487)
1. Reassessing critical maternal antibody threshold in RhD alloimmunization: a 16-year retrospective cohort study.
Walsh CA; Doyle B; Quigley J; McAuliffe FM; Fitzgerald J; Mahony R; Higgins S; Carroll S; McParland P
Ultrasound Obstet Gynecol; 2014 Dec; 44(6):669-73. PubMed ID: 24706487
[TBL] [Abstract][Full Text] [Related]
2. Anti-RH1 alloimmunization: At what maternal antibody threshold is there a risk of severe fetal anemia?
Ghesquière L; Leroy J; Deken V; Tournier A; Vaast P; Subtil D; Delsalle A; Alluin G; Garabedian C; Houfflin-Debarge V
Transfusion; 2023 Mar; 63(3):629-637. PubMed ID: 36734370
[TBL] [Abstract][Full Text] [Related]
3. The effect of fetal anemia on fetal cardiac troponin T in pregnancies complicated by RhD alloimmunization.
Nomura RM; Brizot Mde L; Liao AW; Nishie EN; Zugaib M
J Matern Fetal Neonatal Med; 2013 Feb; 26(3):246-9. PubMed ID: 23013237
[TBL] [Abstract][Full Text] [Related]
4. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation.
Walsh CA; Russell N; McAuliffe FM; Higgins S; Mahony R; Carroll S; McParland P
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):235-9. PubMed ID: 24075591
[TBL] [Abstract][Full Text] [Related]
5. Determination of optimal timing of serial in-utero transfusions in red-cell alloimmunization.
Friszer S; Maisonneuve E; Macé G; Castaigne V; Cortey A; Mailloux A; Pernot F; Carbonne B
Ultrasound Obstet Gynecol; 2015 Nov; 46(5):600-5. PubMed ID: 25523966
[TBL] [Abstract][Full Text] [Related]
6. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
Moise KJ
Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive diagnosis of fetal anemia due to maternal red-cell alloimmunization.
Ahmed B; Ghaffari Z; Ismail RS; Saleh N
Saudi Med J; 2005 Feb; 26(2):256-9. PubMed ID: 15770301
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics of Jra Alloimmunization in Pregnancy: A Case Series.
Kanagawa T; Fujikawa E; Mimura K; Endo M; Sasahara J; Kimura T; Mitsuda N; Ishii K
Fetal Diagn Ther; 2019; 46(6):433-439. PubMed ID: 31434085
[TBL] [Abstract][Full Text] [Related]
9. Management of isoimmunization in the presence of multiple maternal antibodies.
Spong CY; Porter AE; Queenan JT
Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
[TBL] [Abstract][Full Text] [Related]
10. Management of anti-Jka alloimmunization.
Franco A; Rossi K; Krugh D; O'Shaughnessy R
J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
[TBL] [Abstract][Full Text] [Related]
11. A curious case of anti-D antibody titer.
Hensley JG; Coughlin KP; Klein LL
J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
[TBL] [Abstract][Full Text] [Related]
12. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
[TBL] [Abstract][Full Text] [Related]
13. Management of red blood cell alloimmunization in pregnancy.
Ghesquière L; Garabedian C; Coulon C; Verpillat P; Rakza T; Wibaut B; Delsalle A; Subtil D; Vaast P; Debarge V
J Gynecol Obstet Hum Reprod; 2018 May; 47(5):197-204. PubMed ID: 29476829
[TBL] [Abstract][Full Text] [Related]
14. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
15. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
Scheier M; Hernandez-Andrade E; Fonseca EB; Nicolaides KH
Am J Obstet Gynecol; 2006 Dec; 195(6):1550-6. PubMed ID: 16796991
[TBL] [Abstract][Full Text] [Related]
16. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
Kamphuis MM; Lindenburg I; van Kamp IL; Meerman RH; Kanhai HH; Oepkes D
Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
[TBL] [Abstract][Full Text] [Related]
17. The value of middle cerebral artery systolic velocity for initial and subsequent management in fetal anemia.
Deren O; Onderoglu L
Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):26-30. PubMed ID: 11803096
[TBL] [Abstract][Full Text] [Related]
18. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
Babinszki A; Lapinski RH; Berkowitz RL
Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
[TBL] [Abstract][Full Text] [Related]
20. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
